Şunu aradınız:: lapkricio (Litvanca - İngilizce)

lapkricio 8­10 d.
8-10 november

2002 m. lapkricio 20 d.
20 november 2002

1995 lapkricio 30 paskutinio atnaujinimo data:
30 november 1995 date of last renewal:

2001 m. lapkricio 20 d.) , cia (ll:
20 november 2001) , here (all:

rinkodaros teis buvo pratsta 2004 lapkricio 25 d.
the marketing authorisation was renewed on 25 november 2004.

sios procedros buvo pradtos 2004 m. lapkricio mn.
these review procedures were started in november 2004.

2000 m. lapkricio 16 d.paskutins perregistracijos data:
16 november 2000 date of last renewal:

registravimo liudijimas buvo atnaujintas 2005 m. lapkricio 29 d.
the marketing authorisation was renewed on 29 november 2005.

si santrauka paskutin kart buvo atnaujinta 2006 m. lapkricio mn.
this summary was last updated in november 2006.

1999 m. lapkricio 16 d.2003 m. sausio 15 d.10.
10 date of revision 13/11/2007

2006 m. lapkricio 16 d. nuomon buvo patvirtinta bendru sutarimu.
a positive opinion was adopted by consensus on 16 november 2006.

prasymas pateikti papildomos informacijos pateiktas 2006 m. lapkricio 16 d.
a request for supplementary information was adopted on 16 november 2006.

pirmojo registravimo data:2001 m. lapkricio 27 d.perregistravimo data:
date of first authorisation:27.11.2001 date of last renewal:

2007 m. lapkricio 15 d. bendru sutarimu buvo priimta teigiama nuomon.
a positive opinion was adopted by consensus on 15 november 2007.

jis buvo atnaujintas 2000 m. lapkricio 30 d. ir 2005 m. lapkricio 30 d.
this was renewed on 30 november 2000 and 30 november 2005.

2000 m. lapkricio 16 d.informacija apie vaisto skyrim pateikta ant isorins pakuots.
information on the prescription status of this product may be found on the outer package.

bendrovei pateikus papildomos informacijos, registracija isskirtinmis aplinkybmis panaikinta 2002 m. lapkricio 12 d.
as the company had supplied the additional information requested, the " exceptional circumstances " ended on 12 november 2002.

cekija, ispanija ir portugalija pateik emea informacij apie nesutarimo priezastis 2006 m. lapkricio 30 d.
the czech republic, spain and portugal referred the reasons for disagreement to the emea on 30 november 2006.

bendrovei pateikus reikalaujam papildom informacij, registracija isimtinmis slygomis panaikinta 2004 m. lapkricio 30 d.
as the company had supplied the additional information requested, the " exceptional circumstances " ended on 30 november 2004.

2003 m. lapkricio mn. traukta indikacija,, kontrastinis preparatas magnetinio rezonanso angiografijai atlikti ".
in june 2005, a mr procedure started for a type ii variation to add the indication of " contrast enhanced mri of other body regions: liver, kidneys " and the following posology and method of administration/dosage: